Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 65 (RN7SKP65)
- Target
- RN7SKP65
- Molecular classification
- Other (pseudogene), Non-coding RNA pseudogene
01
Overview
RN7SKP65, or RN7SK pseudogene 65, is a human pseudogene related to the functional RN7SK small nuclear RNA gene[5]. Unlike the functional RN7SK gene, which is essential in the regulation of transcriptional elongation and Pol II pause-release and plays key roles in cell cycle regulation and differentiation[2][3][4], RN7SKP65 lacks known coding potential and is not known to produce a functional RNA product. Thus, it is not classified as a therapeutic target, does not encode a protein or regulatory RNA with characterized function, and has no established role in disease or drug targeting[5].
- Other names
- RN7SKP65RNA, 7SK small nuclear pseudogene 65
Beyond the preview
Go deeper on RN7SK pseudogene 65 (RN7SKP65).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RN7SK pseudogene 65 (RN7SKP65).